Identification of potential hub genes and biological mechanism in rheumatoid arthritis and non-small cell lung cancer via integrated bioinformatics analysis

被引:2
|
作者
An, Junsha [1 ,2 ]
Chen, Pingting [1 ,2 ]
Li, Xin [1 ,2 ]
Li, Xiuchuan [3 ]
Peng, Fu [1 ,2 ,4 ]
机构
[1] Sichuan Univ, Key Lab Drug Targeting & Drug Delivery Syst, Sichuan Engn Lab Plant Sourced Drug, Educ Minist, Chengdu 610041, Peoples R China
[2] Sichuan Univ, Sichuan Res Ctr Drug Precis Ind Technol, West China Sch Pharm, Chengdu 610041, Peoples R China
[3] Gen Hosp Western Theater Command, Dept Cardiol, Chengdu 610083, Peoples R China
[4] Sichuan Univ, West China Sch Pharm, 17 Sect 3 Renmin South Rd, Chengdu 610041, Peoples R China
来源
TRANSLATIONAL ONCOLOGY | 2024年 / 45卷
基金
中国国家自然科学基金;
关键词
Rheumatoid arthritis; Non-small cell lung cancer; Ptprc; Immune infiltration; Bioinformatics analysis; TUMOR-NECROSIS-FACTOR; ASSOCIATIONS; CD45;
D O I
10.1016/j.tranon.2024.101964
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although there is evidence of the association between RA and NSCLC, little is known about their interaction mechanisms. The aim of this study is to identify potential hub genes and biological mechanism in RA and NSCLC via integrated bioinformatics analysis. Methods: The gene expression datasets of RA and NSCLC were downloaded to discover and validate hub genes. After identifying DEGs, we performed enrichment analysis, PPI network construction and module analysis, selection and validation of hub genes. Moreover, we selected the hub gene PTPRC for expression and prognosis analysis, immune analysis, mutation and methylation analysis in NSCLC. Finally, we performed real-time PCR, colony formation assay, wound healing assay, transwell invasion assay, sphere formation assay and western blotting to validate the role of PTPRC in A549 cells. Results: We obtained 320 DEGs for subsequent analysis. Enrichment results showed that the DEGs were mainly involved in Th1, Th2 and Th17 cell differentiation. In addition, four hub genes, BIRC5, PTPRC, PLEK, and FYN, were identified after selection and validation. These hub genes were subsequently shown to be closely associated with immune cells and related pathways. In NSCLC, PTPRC was downregulated, positively correlated with immune infiltration and immune cells. Experiments showed that PTPRC could promote the proliferation, migration and invasion, and the ability to form spheroids of A549 cells. In addition, PTPRC could regulate the increased expression of CD45, beta-catenin, c-Myc and LEF1 proteins. Conclusions: This study explored the hub genes and related mechanisms of RA and NSCLC, demonstrated the central role of the inflammatory response and the adaptive immune system, and identified PTPRC as an immunerelated biomarker and potential therapeutic target for RA and NSCLC patients. In addition, PTPRC can significantly promote the proliferation, migration and invasion of A549 cells, and its mechanism may be to promote the EMT process by regulating the Wnt signaling pathway and promote cell stemness, which in turn has a promoting effect on A549 cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis
    Zeng, Yu
    Li, Nanhong
    Chen, Riken
    Liu, Wang
    Chen, Tao
    Zhu, Jinru
    Zeng, Mingqing
    Cheng, Junfen
    Huang, Jian
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 7149 - 7164
  • [2] Identification and validation of potential hub genes in rheumatoid arthritis by bioinformatics analysis
    He, Xinling
    Yin, Ji
    Yu, Mingfang
    Qiu, Jiao
    Wang, Aiyang
    Wang, Haoyu
    He, Xueyi
    Wu, Xiao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (09): : 6751 - +
  • [3] Identification of the Shared Gene Signatures and Biological Mechanism in Rheumatoid Arthritis and Non-small Cell Lung Cancer
    An, Ms Junsha
    Peng, Fu
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 812 - 813
  • [4] Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis
    Xie, Mengyan
    Ding, Kun
    Jing, Xinming
    Wei, Yutian
    Shu, Yongqian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Identification of key genes in non-small cell lung cancer by bioinformatics analysis
    Zhang, Li
    Peng, Rui
    Sun, Yan
    Wang, Jia
    Chong, Xinyu
    Zhang, Zheng
    PEERJ, 2019, 7
  • [6] Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values
    Wang, Tengyong
    Chen, Xiaoxuan
    Jing, Fangqi
    Li, Zehua
    Tan, Huaicheng
    Luo, Yiqiao
    Shi, Huashan
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 228
  • [7] Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis
    Gao, Peng
    Ren, Guanghui
    AGING-US, 2021, 13 (19): : 23245 - 23261
  • [8] Identification of hub genes in rheumatoid arthritis through an integrated bioinformatics approach
    Rui Wu
    Li Long
    Qiao Zhou
    Jiang Su
    Wei Su
    Jing Zhu
    Journal of Orthopaedic Surgery and Research, 16
  • [9] Identification of hub genes in rheumatoid arthritis through an integrated bioinformatics approach
    Wu, Rui
    Long, Li
    Zhou, Qiao
    Su, Jiang
    Su, Wei
    Zhu, Jing
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2021, 16 (01)
  • [10] Identification of hub genes and biological pathways in glioma via integrated bioinformatics analysis
    Chen, Lulu
    Sun, Tao
    Li, Jian
    Zhao, Yongxuan
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (06)